Churchill Capital Corp X (NASDAQ:CCCXU) announced the pricing of its upsized $360 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “CCCXU”, Wednesday, May 14, 2025.
The new SPAC aims to conduct a broad search for a business combination target leveraging its teams existing network and expertise.
Churchill Capital Corp X is led by Chief Executive Officer, President and Chairman Michael Klein alongside Chief Financial Officer Jay Taragin. William Sherman is to serve on its Board.
Total SPAC deal count for 2025 year-to-date is now 40. This offering is expected to close on Thursday, May 15, 2025.
BTIG, LLC is acting as sole book-running manager for the offering. Ellenoff, Grossman & Schole LLP is serving as Issuer’s Counsel with White & Case LLP serving as Underwriter’s Counsel. WithumSmith+Brown, PC serves as auditor. Continental Stock Transfer & Trust Company is acting as trustee.
Churchill Capital Corp X (NASDAQ:CCCXU) announced the pricing of its upsized $360 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “CCCXU”, Wednesday, May 14, 2025. The new SPAC aims to conduct a broad search for a business combination target leveraging its teams existing network and expertise. Churchill...
Jena II (NYSE:JENAU) has filed for a $200 million SPAC that brings serial SPAC leader William P. Foley II and his team back into the ring. This pedigree is clear in the terms the team has been able to command with just one right to a 1/20 share in each unit and 24 months to...
At the SPAC of Dawn Investors are set to get an update on Core CPI inflation readings this morning as de-SPACs continue to report on operational advances alongside their first quarter earnings. Among them, eVTOL developer Archer (NYSE:ACHR) noted that it is on track to deliver its first Midnight aircraft to the UAE in the...
Perimeter Acquisition Corp. I (NASDAQ:PMTRU) announced the pricing of its upsized $210 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “PMTRU”, Tuesday, May 13, 2025. The new SPAC aims to combine with a target company with that can contribute to the re-industrialization of the United States economy,...
Horizon Space II (NASDAQ:HSPT) has signed a definitive agreement to combine with clinical stage biotech firm SL Bio Ltd. for $5.57 billion in equity consideration. Taipei, Taiwan-based SL Bio is developing drug candidates to treat several cancer types while also selling over-the-counter beauty products derived from natural extracts. The combined company is expected to trade...